Strategic partnerships CriTech has recently formed strategic alliances with Parasoft UK Ltd. and The Realtime Group, signaling openness to collaboration with established testing and product development partners. This presents a compelling channel for co-selling or joint offerings to medical device manufacturers seeking end-to-end quality assurance and compliance solutions.

Regulatory specialization With ISO 13485:2016 certification and a focus on medical device software across FDA and EU submissions, CriTech positions itself as a go-to partner for firms needing compliant SaMD development, risk management, and documentation support. Leverage this to target manufacturers preparing, renewing, or upgrading regulatory submissions.

Strong first-time approval A 100% first-time approval rate for work products used in submissions suggests high quality and reliability, reducing time-to-market risk for clients. Promote this as a differentiator when competing for high-stakes regulatory projects and long-term maintenance contracts.

AI and cybersecurity focus Specialized capabilities in AI/ML, cybersecurity, and risk management align with growing demand for SaMD that leverages intelligent features while maintaining stringent security and safety standards. Target device manufacturers seeking innovation within compliant software ecosystems.

Industry depth and reach A dedicated medical device software specialist with over 30 years in the space and a revenue range of 25–50 million positions CriTech as a mid-market partner able to scale with growing medtech firms. Consider targeting mid-size manufacturers preparing for complex ISO submissions or multi-class device portfolios.